 | Related Articles |
Brentuximab vedotin in relapsed primary mediastinal large B-cell lymphoma: results from a phase 2 clinical trial.
Blood. 2017 04 20;129(16):2328-2330
Authors: Zinzani PL, Pellegrini C, Chiappella A, Di Rocco A, Salvi F, Cabras MG, Argnani L, Stefoni V
PMID: 28264798 [PubMed - indexed for MEDLINE]
http://ift.tt/2mEPEcs
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου